July 23, 2024

Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38→

July 23, 2024/ Kartik Chandran

Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38

Shin et al, Cell Rep. 2024

July 16, 2024

A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus→

July 16, 2024/ Kartik Chandran

A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus

Ng et al, Front Immunol. 2024

June 18, 2024

Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity→

June 18, 2024/ Kartik Chandran

Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity

Jing et al, Elife. 2024

May 03, 2024

A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants→

May 03, 2024/ Kartik Chandran

A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants

Yang et al, Antib Ther. 2024

April 11, 2024

Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies→

April 11, 2024/ Kartik Chandran

Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies

Wirchnianski et al, PLoS Pathog. 2024

April 04, 2024

Case of Human Orthohantavirus Infection, Michigan, USA, 2021→

April 04, 2024/ Kartik Chandran

Case of Human Orthohantavirus Infection, Michigan, USA, 2021

Goodfellow et al, Emerg Infect Dis. 2024

March 02, 2024

Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- multivalent adjuvanted glycoprotein vaccines→

March 02, 2024/ Kartik Chandran

Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- multivalent adjuvanted glycoprotein vaccines

Felgner et al, Antiviral Res. 2024

February 07, 2024

Visualization of Early RNA Replication Kinetics of SARS-CoV-2 by Using Single Molecule RNA-FISH Combined with Immunofluorescence→

February 07, 2024/ Kartik Chandran

Visualization of Early RNA Replication Kinetics of SARS-CoV-2 by Using Single Molecule RNA-FISH Combined with Immunofluorescence

Pathak et al, Viruses 2024

January 22, 2024

Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge→

January 22, 2024/ Kartik Chandran

Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge

Hsieh C-L et al, Nat Commun 2024